Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Latest News
Overview
Latest News
Video
Coverage
Latest News
Filter by Year:
2023
2022
2021
2020
11-Nov-2021
Pnoc Study In Childhood Brain Cancer Enrols First Patient
10-Nov-2021
Kazia Annual General Meeting Results
4-Nov-2021
Kazia Annual General Meeting Results
29-Oct-2021
Quarterly Activities Report And Appendix 4c
10-Sep-2021
Kazia Therapeutics To Present At Hc Wainwright 23rd Annual Global Investment Conference
2-Sep-2021
Evt801 Phase I Study Receives Full Regulatory Approval
30-Jul-2021
Quarterly Activities Report And Appendix 4c
21-Jul-2021
Kazia Calls For Increased Focus On Brain Cancer Research This Gbm Awareness Day
30-Jun-2021
Kazia Provides Progress Update On Paxalisib And Evt801 Clinical Programs
24-Jun-2021
Manufacturing Patents Granted For Paxalisib In Key Territories; Extend Effective Patent Protection To 2036
Previous
1
2
3
4
5
Next
